Alexander Buko, Ph.D.
Vice President, Business and Product Development
Dr. Buko brings with him over 30 years of pharmaceutical experience with the FDA, Abbott Labs, and most recently with Biogen, Idec where he held the position of Senior Director of Translational Medicine. Alex has successfully led large scale omics projects in neurology, immunology, and oncology. With extensive experience in protein and metabolite based profiling, Alex leads project management and development of HMT’s biomarker-based platforms.
Mark Zbinden, Ph.D.
Sr. Scientific Project Coordinator
Mark Zbinden is a biochemist and educator, and the newest member of HMT. While his thesis work was in molecular neuroscience, he has a diverse scientific background: from artificial bilayer networks to bacterial protein characterization to the impact of lipid maturation in yeast metabolism. Utilizing his passion for education, Dr. Zbinden connects with clients and aids in experimental design, troubleshooting, and data interpretation. Mark is also responsible for Marketing, SNS, and other business development activities.